A Japanese, single-center, open-label, prospective, safety study of AT-04 in healthy people

A Japanese, single-center, open-label, prospective, safety study of AT-04 in healthy people - A Japanese, single-center, open-label, prospective, safety study of AT-04 in healthy people

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029341

Enrollment

Registered

2017-10-03

Start date

2017-10-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subject

Interventions

(1) AT-04 AT-04 is an investigational medical device (unapproved) that concurrently produces magnetic fields (2 kHz and 83.3 MHz) to relieve pain.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Age: Patients aged 20 years of age or older - <80 years (healthy adult at the time of obtaining informed consent) (2) Patients from whom written informed consent can be directly obtained

Exclusion criteria

Exclusion criteria: (1) Patients with expected survival less than 3 years due to malignancies or other reasons (2) Patients using life-sustaining electrical medical devices, such as artificial heart-lung devices (3) Patients using affixed electrical medical devices, such as ECG recorders (4) Patients who are participating in another clinical trial for a pharmaceutical product or medical device (5) Patients with dementia that seriously disturbs activities of daily life (6) Females who wish to become pregnant or are presently pregnant or nursing mothers (if the patient is a woman of childbearing potential, a pregnancy test must be performed) and others.

Design outcomes

Primary

Measure	Time frame
Adverse events, adverse reactions which are related to or undeniable to study treatment, and their frequencies.	—

Countries

Japan

Contacts

Public ContactIn Guto

Japanese Organization for Medical Device Development, Inc. COO

pm@jomdd.com03-6262-3322

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026